These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23338231)

  • 21. A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.
    Dunnill CJ; Al-Tameemi W; Collett A; Haslam IS; Georgopoulos NT
    Oncologist; 2018 Jan; 23(1):84-96. PubMed ID: 28951499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlled clinical trials.
    Shah VV; Wikramanayake TC; DelCanto GM; van den Hurk C; Wu S; Lacouture ME; Jimenez JJ
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):720-734. PubMed ID: 28976026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Smorenburg CH; van der Hoeven JJM
    Eur J Oncol Nurs; 2018 Apr; 33():49-55. PubMed ID: 29551177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
    van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
    Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
    Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry.
    van den Hurk CJ; Peerbooms M; van de Poll-Franse LV; Nortier JW; Coebergh JW; Breed WP
    Acta Oncol; 2012 Apr; 51(4):497-504. PubMed ID: 22304489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Cohen's cross-section trichometer for measuring hair quantity.
    Hendriks MA; Geerts PA; Dercksen MW; van den Hurk CJ; Breed WP
    Dermatol Surg; 2012 Apr; 38(4):631-4. PubMed ID: 22268669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia.
    Auvinen PK; Mähönen UA; Soininen KM; Paananen PK; Ranta-Koponen PH; Saavalainen IE; Johansson RT
    Tumori; 2010; 96(2):271-5. PubMed ID: 20572585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of alopecia and scalp cooling on the well-being of breast cancer patients.
    van den Hurk CJ; Mols F; Vingerhoets AJ; Breed WP
    Psychooncology; 2010 Jul; 19(7):701-9. PubMed ID: 19637250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy-induced alopecia.
    Trüeb RM
    Semin Cutan Med Surg; 2009 Mar; 28(1):11-4. PubMed ID: 19341937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.
    Mols F; van den Hurk CJ; Vingerhoets AJ; Breed WP
    Support Care Cancer; 2009 Feb; 17(2):181-9. PubMed ID: 18560904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cross-section trichometer: a new device for measuring hair quantity, hair loss, and hair growth.
    Cohen B
    Dermatol Surg; 2008 Jul; 34(7):900-10; discussion 910-1. PubMed ID: 18384368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review.
    Lemieux J; Maunsell E; Provencher L
    Psychooncology; 2008 Apr; 17(4):317-28. PubMed ID: 17721909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.
    Cho EK; Lee WK; Im SA; Lee SN; Park SH; Bang SM; Park DK; Park YH; Shin DB; Lee JH
    Oncology; 2005; 68(4-6):333-40. PubMed ID: 16020960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of chemotherapy-induced hair loss by scalp cooling.
    Grevelman EG; Breed WP
    Ann Oncol; 2005 Mar; 16(3):352-8. PubMed ID: 15642703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hair mass index obtained by cross-section trichometry: an objective and clinically useful parameter to quantify hair in chemotherapy-induced alopecia.
    Vleut RE; van Poppel JE; Dercksen MW; Peerbooms M; Houterman S; Breed WP
    Support Care Cancer; 2013 Jul; 21(7):1807-14. PubMed ID: 23338231
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.